These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18447834)

  • 41. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
    Gibson CM; Karha J; Murphy SA; de Lemos JA; Morrow DA; Giugliano RP; Roe MT; Harrington RA; Cannon CP; Antman EM; Califf RM; Braunwald E;
    J Am Coll Cardiol; 2004 Apr; 43(7):1170-6. PubMed ID: 15063425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study).
    Singh RK; Trailokya A; Naik MM
    J Assoc Physicians India; 2015 Apr; 63(4):30, 32-5. PubMed ID: 26591167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of the red cell distribution width and neutrophil/lymphocyte ratio in predicting thrombolysis failure in patients with an ST-segment elevation myocardial infarction.
    Baysal E; Çetin M; Yaylak B; Altntaş B; Altndağ R; Adyaman Ş; Altaş Y; Kaya İ; Sevuk U
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):274-8. PubMed ID: 25396765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
    Solhpour A; Chang KW; Balan P; Cai C; Sdringola S; Denktas AE; Smalling RW; Anderson HV
    Am J Cardiol; 2014 Jan; 113(1):60-3. PubMed ID: 24207074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
    Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E
    Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.
    Sinnaeve PR; Alexander JH; Bogaerts K; Belmans A; Wallentin L; Armstrong P; Adgey JA; Tendera M; Diaz R; Soares-Piegas L; Vahanian A; Granger CB; Van De Werf FJ
    Am Heart J; 2004 Jun; 147(6):993-8. PubMed ID: 15199346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction.
    Melandri G; Vagnarelli F; Calabrese D; Semprini F; Nanni S; Branzi A
    Vasc Health Risk Manag; 2009; 5(1):249-56. PubMed ID: 19436656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prehospital thrombolysis acute coronary syndrome in patients with acute left bundle branch block].
    Baev VM; Simanov DR; Sosedkov AB
    Kardiologiia; 2012; 52(6):10-3. PubMed ID: 22839663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does prehospital thrombolysis increase the proportion of patients who have an aborted myocardial infarction?
    Jackson L; Kendall J; Castle N
    Emerg Med J; 2009 Mar; 26(3):206-9. PubMed ID: 19234016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).
    Goldstein P; Wiel E
    Minerva Anestesiol; 2005 Jun; 71(6):297-302. PubMed ID: 15886591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
    Sinnaeve PR; Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Lambert Y; Danays T; Soulat L; Halvorsen S; Ortiz FR; Vandenberghe K; Regelin A; Bluhmki E; Bogaerts K; Van de Werf F;
    Circulation; 2014 Sep; 130(14):1139-45. PubMed ID: 25161043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does coronary angioplasty after timely thrombolysis improve microvascular perfusion and left ventricular function after acute myocardial infarction?
    Agati L; Funaro S; Madonna M; Sardella G; Garramone B; Galiuto L
    Am Heart J; 2007 Jul; 154(1):151-7. PubMed ID: 17584568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
    de Lemos JA; Gibson CM; Antman EM; Murphy SA; Morrow DA; Schuhwerk KC; Schweiger M; Coussement P; Van de Werf F; Braunwald E;
    Am Heart J; 2001 Apr; 141(4):592-8. PubMed ID: 11275925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
    Gibson CM; Murphy SA; Kirtane AJ; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2004 Sep; 44(5):980-7. PubMed ID: 15337207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian Registry.
    Iyengar SS; Nair T; Sathyamurthy I; Hiremath JS; Jadhav U; Kumbla D; Jain RK; Srinivasan M; Sahoo PK; Chawla K; Katiyal VK
    Indian Heart J; 2009; 61(5):480-1. PubMed ID: 20635768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction.
    Arntz HR; Wenzel V; Dissmann R; Marschalk A; Breckwoldt J; Müller D
    Resuscitation; 2008 Feb; 76(2):180-4. PubMed ID: 17728040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports.
    Arous S; Haboub M; El Ghali Benouna M; Bentaoune T; Habbal R
    J Med Case Rep; 2017 Jun; 11(1):154. PubMed ID: 28601092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.